L8 + L9: Immunoengineering & translational considerations Flashcards

1
Q

What do T helper cells do?

A

They travel to the infection where they secrete cytokines for inflammation and phagocytosis.

They activate: B-cells and cytotoxic T-cells
- CD8 > cytoxic T cells
- CD4 > T helper cell

Activated when their receptor interacts with a MHC class II molecule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do dendritic cells do?

A

They are named because of their many, long processes that resemble neuronal dendrites which makes them very efficient in making contact with foreign materials.

Dendritic cells are expert messenger cells (for the adaptive system). They bind to antigens and activate T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between MHC class I and II?

A

MHC I: on all cells, present endogenous protein (‘I am one of us, don’t kill me’).
MHC II: APCs only, present non-self antigen (to kill).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dendritic cells can mature into 2 types. What are those and what are their characteristics?

A

Mature dendritic cell (mDC)
- high MHC II
- secretion of inflammatory cytokines; IL-12, IFN-y

Tolerogenic dendritic cell (tDC)
- low MHC II
- Secretion of anti-inflammatory cytokines; IL-10, TGF-b1
- Effective induction of regulatory T cell types
–> it inhibits inflammation in every way possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T-cell activation occurs from 3 signals?
How is this called?

A
  1. Antigen presentation
  2. Co-stimulation
  3. Cytokines
    This is called the immunological synapse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain Signal 1: antigen presentation.

A

T cells are generated in the thymus and are programmed to be specific for one particular antigen. Once they leave the thymus, they circulate throughout the body until they recognize their antigen on the surface of antigen-presenting cells (APCs). Both CD4 helper T cells and CD8 cytotoxic T cells bind to the antigen (held in a structure called the MHC complex). This triggers the activation of the T cells.
Dendritic cell has eaten anything and presents this to the T cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain Signal 2: co-stimulation.

A

This is a signal to activate the T cells and respond to the threat. This leads to the production of many T cells that recognize the antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain Signal 3: Cytokines.

A

Once the T cell has received a specific antigen signal (1) and a general signal (2), it receives more instructions in the form of cytokines. They are secreted by cytokines. These determine which type of responder the cell will become:
T helper cell → TH1 (when exposed to IL-12), TH2 (IL-4), or TH17 (IL-6, IL-23). Each of these cells performs a specific task in the tissue and in developing further immune responses. (Cytokines → TH cell polarization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Licensing=

A

? Not sure?
If dentritic cells comes along a antigen and becomes activated, there are co-stimulatory signals CD40-CD40L. They show it to T helper cells via MHC class II. It can also show DC-CD8+ to cytotoxic T cells via the MHC class I receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antigenicity=

A

The ability of foreign material (antigen) to bind to an antibody or an activated T cell (having signal 1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Immunogeneicity=

A

The ability to elicit an immune response (first triggering the innate immune response and later the adaptive immune response).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the purpose of peripheral tolerance by DCs?

A

The main purpose of peripheral tolerance is to ensure that self-reactive T and B cells which escaped central tolerance do not cause autoimmune disease. It presents immune response to harmless antigens and allergens (e.g. food).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 4 ways of peripheral tolerance by DCs?

A
  1. Ignorance; is has the antigen, but it doesn’t show it. The mechanism of ignorance is when the affinity to antigen is too low to elicit T cell activation.
  2. Anergy; the antigen is shown, but there is no pro-inflammatory signal. There is an ‘are you sure?’-button. This is used as an checkpoint. So, signal 1 is present, but signal 2 isn’t. Also, without pro-inflammatory cytokines, co-stimulatory molecules will not be expressed on the surface of the APC.
  3. Phenotypic skewing; cytokines are anti-inflammatory (il-10).
  4. Apoptosis; self-destruct switch.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does cancer immunotherapy aims to do? And what are the 4 approaches?

A

Boost/ improve the natural anti-tumor immune response.
1. Blocking inhibitory signaling pathways on T cells.
2. Increasing the number of effector T cells.
3. Vaccination with tumor antigens.
4. Cytokine therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain blocking inhibitory signaling pathways on cells (cancer immunotherapy)

A

Immune checkpoint= are regulators of the immune system. These pathways are crucial for self-toleance, which prevents the immune system from attacking random cells. Some cancers can protect themselves from attack by stimulating or blocking receptors for immune checkpoint targets (on T cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain increasing the number of effector T cells (cancer immunotherapy)

A

Injecting T cells.
Adoptive T cell therapy is a form of passive immunization by the transfusion of T cells. They are activated by the presence of APCs such as DCs that present tumor antigens.

17
Q

Explain vaccination with tumor antigens (cancer immunotherapy)

A

DC-based vaccination. Either take dendritic cells out of the body, show antigens, make more, and put them back in the body. You can also do this inside the body. E.g. by particles.

18
Q

Explain cytokine therapy (cancer immunotherapy)

A

Injection of cytokines to directly stimulate the immune system. IL-2 and IFN-a to boost T cell activation and survival.

19
Q

What is the common downside of cancer immunotherapy?

A

Systemic administration (=route of administration so that the entire body is affected). This hampers efficacy and induces systemic toxicity.

20
Q

What are the two types to create a synthetic immune niche?

A

Scaffold-based adoptive cell transfer.
Scaffold-based cancer baccine.

21
Q

Explain the scaffold-based adoptive cell transfer.

A

Deliver & harbour activated cells (T cells, DCs).
Control over cellular location & better viability.

Instead of injecting, you bring the cells into the body using the scaffold. Either pre-stimulated T cells or antigen-loaded activated DCs.
1) Take T cels from the body, activate in the lab with factors, put on a scaffold, implant them back in the body, create a priming immune niche.
OR
2) take out cells from the patient, show antigen, put in scaffold with survival factors, create a niche for cells to be happy, place close to the tumor, high concentration close to tumor, they activate T cells

22
Q

Explain the scaffold-based cancer vaccine.

A

Niche to attract & activate cells (T cells, DCs).
Sustained availability of immunomodulatory at a localized site.

You need: tumor attractant + antigen + adjuvant.
Adjuvant = a drug/substance that is used to increase the efficacy or potency of certain drugs.
Implant cells in scaffold > secrete cytokines > cells come in > release signals > activate T cells.

23
Q

What are the pros and cons of scaffold-based adoptive cell transfer?
What are the pros of scaffold-based cancer vaccines?

A

Pros scaffold-based adoptive cell transfer:
+ Control over cellular localization.
+ Higher cell persistence (shear stress, sustained availability of survival factors).

Cons scaffold-based adoptive cell transfer:
- Requires high number of cells (inefficient).
- Poor T cell persistence and tumor localization.
- Serious side effects.

Pros scaffold-based cancer vaccines:
+ Sustained availability of immunomodulatory at a localized site.
+ Matrix supportive of immune cell activation.

24
Q

How can you deliver these synthetic immune niches?

A

Via implantation
Via injection and gelation in situ
Via injection of pre-formed scaffold

25
Q

How does age influence the host response?

A

Aging > redox imbalance > chronic oxidative stress.
(levels of factors in the blood are higher. Increase in TNFa, IL1b, IL2, IL6, IL8, RANTES, VCAM1, ICAM1, selectines).